Li F, Yu W, Zhou X, Hou J, Gao Y, Zhang J
Int J Mol Sci. 2024; 25(11).
PMID: 38891773
PMC: 11171779.
DOI: 10.3390/ijms25115585.
Chen S, Chen H, Wang X, Zhang D, Zhang L, Cheng J
An Bras Dermatol. 2024; 99(4):535-545.
PMID: 38548549
PMC: 11220918.
DOI: 10.1016/j.abd.2023.08.010.
Baran M, Miziak P, Stepulak A, Cybulski M
Int J Mol Sci. 2024; 25(1).
PMID: 38203666
PMC: 10779230.
DOI: 10.3390/ijms25010497.
Quan J, Wen X, Su G, Zhong Y, Huang T, Xiong Z
Nat Commun. 2023; 14(1):8525.
PMID: 38135684
PMC: 10746710.
DOI: 10.1038/s41467-023-44179-x.
Podyacheva E, Toropova Y
Int J Mol Sci. 2023; 24(9).
PMID: 37175631
PMC: 10178434.
DOI: 10.3390/ijms24097925.
Anti-aging Strategies and Topical Delivery of Biopolymer-based Nanocarriers for Skin Cancer Treatment.
Ramaraj J, Narayan S
Curr Aging Sci. 2023; 17(1):31-48.
PMID: 36941817
DOI: 10.2174/1874609816666230320122018.
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma.
Gelli E, Soncini D, Becherini P, Martinuzzi C, Todoerti K, Cagnetta A
Blood Adv. 2023; 7(14):3472-3478.
PMID: 36897214
PMC: 10362259.
DOI: 10.1182/bloodadvances.2022009035.
The sirtuin family in health and disease.
Wu Q, Zhang T, Chen H, Yu X, Lv J, Liu Y
Signal Transduct Target Ther. 2022; 7(1):402.
PMID: 36581622
PMC: 9797940.
DOI: 10.1038/s41392-022-01257-8.
Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer.
Raghu S, Bangalore Prabhashankar A, Shivanaiah B, Tripathi E, Sundaresan N
Subcell Biochem. 2022; 100:337-360.
PMID: 36301499
DOI: 10.1007/978-3-031-07634-3_10.
The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer.
You Q, Wang J, Yu Y, Li F, Meng L, Chen M
Apoptosis. 2022; 27(11-12):883-898.
PMID: 35915188
PMC: 9617843.
DOI: 10.1007/s10495-022-01751-y.
4-phenylpyridine suppresses UVB-induced skin inflammation by targeting c-Src in vitro and in vivo.
Kim J, Kang H, Kim M, Lim S, Lee C, Kim K
J Cell Mol Med. 2022; 26(14):3891-3901.
PMID: 35686492
PMC: 9279582.
DOI: 10.1111/jcmm.17422.
Interleukin-38 promotes skin tumorigenesis in an IL-1Rrp2-dependent manner.
Zhou H, Zhao Q, Yue C, Yu J, Zheng H, Hu J
EMBO Rep. 2022; 23(6):e53791.
PMID: 35578812
PMC: 9171418.
DOI: 10.15252/embr.202153791.
Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer.
Han Q, Xie Q, Li F, Cheng Y, Wu T, Zhang Y
Theranostics. 2021; 11(13):6526-6541.
PMID: 33995674
PMC: 8120217.
DOI: 10.7150/thno.53886.
Bioinformatics Analysis of the SIRT Family Members and Assessment of Their Potential Clinical Value.
Liu M, Yu J, Jin H, Wang S, Ding J, Xing H
Onco Targets Ther. 2021; 14:2635-2649.
PMID: 33883907
PMC: 8055293.
DOI: 10.2147/OTT.S298616.
The Two-Faced Role of SIRT6 in Cancer.
Fiorentino F, Carafa V, Favale G, Altucci L, Mai A, Rotili D
Cancers (Basel). 2021; 13(5).
PMID: 33800266
PMC: 7962659.
DOI: 10.3390/cancers13051156.
Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B-cell lymphoma 2.
An J, Yang J, Yao Y, Lu K, Zhao Z, Yu M
Oncol Lett. 2021; 21(4):293.
PMID: 33732369
PMC: 7905630.
DOI: 10.3892/ol.2021.12554.
SIRT6 Maintains Redox Homeostasis to Promote Porcine Oocyte Maturation.
Li Y, Miao Y, Chen J, Xiong B
Front Cell Dev Biol. 2021; 9:625540.
PMID: 33718364
PMC: 7947247.
DOI: 10.3389/fcell.2021.625540.
SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice.
Becherini P, Caffa I, Piacente F, Damonte P, Vellone V, Passalacqua M
Cancer Metab. 2021; 9(1):6.
PMID: 33482921
PMC: 7821730.
DOI: 10.1186/s40170-021-00240-1.
Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators.
Kratz E, Solkiewicz K, Kubis-Kubiak A, Piwowar A
Int J Mol Sci. 2021; 22(2).
PMID: 33435263
PMC: 7827102.
DOI: 10.3390/ijms22020630.
Emerging roles of SIRT6 in human diseases and its modulators.
Liu G, Chen H, Liu H, Zhang W, Zhou J
Med Res Rev. 2020; 41(2):1089-1137.
PMID: 33325563
PMC: 7906922.
DOI: 10.1002/med.21753.